TABLE 3.
Control | NFD +Solvent | HFD +Solvent | UDCA (40.0) + HFD | I‐ol (0.4) + HFD | I‐ol (4.0) + HFD | I‐ol (40.0) + HFD | I‐an (0.4) + HFD | I‐an (4.0) + HFD | I‐an (40.0) + HFD | |
---|---|---|---|---|---|---|---|---|---|---|
Steatosisa | 0 | 0 | 1 | 0–1 | 0–1 | 0 | 0–1 | 0–1 | 0–1 | 0–1 |
Balooninga | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0–1 | 1 | 0–1 |
Inflammation b | 0 | 0 | 2 | 1 | 1–2 | 1 | 1 | 1 | 1 | 1 |
Steatosis and ballooning: 0, none; 1, ≤25%; 2, 26–50%; 3, ≥51–75% of liver parenchyma.
Inflammation: 0, none; 1, <5 signs of inflammation; 2, >5 signs of inflammation in the microscopic field at 40x magnification.